ClinicalTrials.Veeva

Menu

Characterization and Outcome of Children With Leukodystrophy: An Observational Study at Sohag University Hospital

S

Sohag University

Status

Unknown

Conditions

Children With Leukodystrophy

Treatments

Device: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT04781010
Soh-Med-21-02-01

Details and patient eligibility

About

Leukodystrophies are heterogeneous genetic disorders characterized by the selective involvement of white matter in the central nervous system (CNS) (1, 2). Inherited leukodystrophies are diseases of the myelin, including abnormal myelin development, hypomyelination, or degeneration of myelin (3, 4).

Most of these disorders fall into one of three categories; lysosomal storage diseases, peroxisomal disorders, and diseases caused by mitochondrial dysfunction and each leukodystrophy has distinctive clinical, biochemical, pathologic, and radiologic features (5).

Enrollment

100 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The patients fulfilling all the following criteria will be included:

    1. Age ≤ 18 years.
    2. The presence of typical clinical, biochemical, and neuroimaging features of leukodystrophies.

Exclusion criteria

  • 1- Children who have coexistent genetic disorders. 2- Children who have cerebral malformations. 3- History of perinatal asphyxia. 4- History of head trauma or intracranial hemorrhage. 5- Acquired CNS myelin disorders, such as multiple sclerosis and related acquired demyelinating processes, infectious and post-infectious white matter damage, toxic injuries and non-genetic vascular insults.

Trial contacts and locations

0

Loading...

Central trial contact

Abdelraheem Abdrabu, Professor; Nagat Mohamed, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems